Drug resistant Tuberculosis: A review

JL Khawbung, D Nath, S Chakraborty - … immunology, microbiology and …, 2021 - Elsevier
Tuberculosis (TB) was announced as a global emergency in 1993. There was an alarming
counter attack of TB worldwide. However, when it was known that TB can be cured …

Design and synthesis of hybrid compounds as novel drugs and medicines

AH Alkhzem, TJ Woodman, IS Blagbrough - RSC advances, 2022 - pubs.rsc.org
The development of highly effective conjugate chemistry approaches is a way to improve the
quality of drugs and of medicines. The aim of this paper is to highlight and review such …

[BUKU][B] WHO operational handbook on tuberculosis. Module 4: treatment-drug-susceptible tuberculosis treatment

World Health Organization - 2021 - books.google.com
Page 1 WHO Module 4: Treatment Drug-susceptible tuberculosis treatment operational
handbook on tuberculosis World Health Organization Page 2 WHO operationa handbook …

Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials

JM Caster, AN Patel, T Zhang… - Wiley Interdisciplinary …, 2017 - Wiley Online Library
Nanomedicine is a relatively new field that is rapidly evolving. Formulation of drugs on the
nanoscale imparts many physical and biological advantages. Such advantages can in turn …

Targeting metalloenzymes for therapeutic intervention

AY Chen, RN Adamek, BL Dick, CV Credille… - Chemical …, 2018 - ACS Publications
Metalloenzymes are central to a wide range of essential biological activities, including
nucleic acid modification, protein degradation, and many others. The role of metalloenzymes …

The structure of the human mitochondrial ribosome

A Amunts, A Brown, J Toots, SHW Scheres… - Science, 2015 - science.org
The highly divergent ribosomes of human mitochondria (mitoribosomes) synthesize 13
essential proteins of oxidative phosphorylation complexes. We have determined the …

[HTML][HTML] Public health burden of antimicrobial resistance in Europe

E Tacconelli, MD Pezzani - The Lancet Infectious Diseases, 2019 - thelancet.com
Antimicrobial resistance is one of the greatest challenges of the 21st century. Evaluation of
the public health burden of antimicrobial resistance, which is needed to drive policy …

A new strategy to fight antimicrobial resistance: the revival of old antibiotics

N Cassir, JM Rolain, P Brouqui - Frontiers in microbiology, 2014 - frontiersin.org
The increasing prevalence of hospital and community-acquired infections caused by
multidrug-resistant (MDR) bacterial pathogens is limiting the options for effective antibiotic …

The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells

V Dartois - Nature Reviews Microbiology, 2014 - nature.com
For the successful treatment of pulmonary tuberculosis, drugs need to penetrate complex
lung lesions and permeate the mycobacterial cell wall in order to reach their intracellular …

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

SD Ahuja, D Ashkin, M Avendano, R Banerjee… - 2012 - journals.plos.org
Background Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic,
expensive, and has generally poor outcomes. We undertook an individual patient data meta …